For Media Inquiries:
Tired of being “the sucker at the table,” a group representing Fortune 500 companies has formed a lobby to push congressional drug-pricing policies that focus beyond Medicare. Employers’ Prescription for Affordable Drugs has described its goal as “to mobilize large employers to drive down prescription drug costs by advocating for public policies based on increased competition, transparency and value.”
Legislation aiming to reduce drug prices has thus far focused on changes to federal programs such as Medicare. But Walmart, Pepsi, and other large companies provide employer-sponsored health insurance to more than 150 million Americans, making them the largest footers of health bills.
Rising drug costs in the United States are a pressing concern not only for patients who need to receive those drugs, but also for employers. The Employers’ Prescription for Affordable Drugs (EmployersRx) is a coalition that aims to tackle this problem by working with policy makers and stakeholders to encourage and facilitate more transparency, competition, and value in the healthcare system.
Lisa Zamosky joins PBGH on January 20, 2020 as Chief Communications Officer. Lisa brings extensive communications and healthcare expertise to PBGH, where she will help accelerate PBGH’s vision of improving health outcomes, experience, and affordability for consumers and purchasers.
Read the statement issued by PBGH CEO Elizabeth Mitchell on the settlement of the lawsuit against Sutter Health System regarding alleged consolidation practices.
Susan Au, CPA, MBA joins PBGH on January 27, 2020 as Chief Financial Officer.
PBGH has launched the Employers’ Prescription for Affordable Drugs (EmployersRx), a coalition uniting employers in advocacy for policies that will address our nation’s biggest health care challenge—the high cost of prescription drugs.
The Pacific Business Group on Health (PBGH) recently asked our members to take part in a poll to assess their plans to support workers with young children unable to return to school due to the COVID-19 health crisis and to address the health inequities that COVID-19 has exacerbated.
This event has been postponed to a later date.